Byrne Wallace Shields LLP‘s intellectual property team assists in a range of contentious and non-contentious IP mandates, including brand and design protection. Considered a go-to for clients in the life sciences sector, Colin Sainsbury leads the non-contentious IP offering and regularly drafts and negotiates licensing, supply and service agreements.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Personal attention to detail and responsiveness makes this team unique.’
- 'Excellent to deal with good communication and easy to understand.'
- 'Colin Sainsbury is a long standing and well renowned professional.'
- ‘Jane O'Grady is clearly a subject matter expert in the Intellectual Property domain and all my questions were comprehensively answered. Jane also adopts a commercial pragmatic approach which is especially helpful.’
- ‘Strong teamwork and culture. Good coordination amongst partners in terms of responding to client queries.’
Key clients
- Starbucks Corporation
- Headstuff Podcasts
- Corpay
- Suil Vision
- UltraGreen.ai/Renew Pharma
- Neuromod Devices Limited
- Priothera Limited
- Xeolas Pharmaceuticals Limited
- Versono Medical Limited
- Warburton Technology
- European Circular Bioeconomy Fund
- Q3 Medical Devices Limited
Work highlights
Advising MVM Partners (the lead investor) and OrbiMed in relation to the announced $80m Series B financing of ProVerum Limited
Advising StatisticaMedica on the negotiation and successful conclusion of a number of complex master services agreements with multinational life sciences companies.
Practice head
Colin Sainsbury
Other key lawyers
Victor Timon; Laura Greene